.

Def Leppard, Motley Crue, Poison Tour Has Sold Over A Million Tickets


William Lee | 02-03-2020

Share on Facebook Share on Twitter Pin it Share on Reddit email this article

Def Leppard

Def Leppard, the reunited Motley Crue and Poison's upcoming North American stadium tour has already sold over one million tickets, according to Billboard.

"The Stadium Tour" will be kicking off on June 18th in Jacksonville, Florida and will mark the official live return on Motley Crue following their farewell tour.

Ticket sales for the tour has reportedly already grossed $130 million in advance tickets sales, as well as $5 million from VIP offerings.

Motley Crue manager Allen Kovac shared his reaction with Billboard. He said, "One band [Def Leppard] as inducted into the Rock And Roll Hall Of Fame and another [Motley Crue] has one of the biggest rock books ever that was turned into a film and the film was seen by tens of millions . We knew co-headlining would dramatically lift the ticket sales."


Related Stories


Def Leppard Guitarist Not 100% Sure Motley Crue Stadium Tour Will Happen

Motley Crue, Def Leppard, Poison Announce New Stadium Tour Dates

Def Leppard 'Tiding Up' Some Historical Stuff and Pondering New Album

New Motley Crue, Def Leppard, Poison Stadium Tour Dates Coming ASAP

Def Leppard Plan Special RSD Release

Motley Crue, Def Leppard and Poison Postpone Stadium Tour

Motley Crue, Def Leppard, Poison Stadium Tour Update Expected Monday

Def Leppard Release Live 'Hysteria' Video

Motley Crue, Def Leppard, Poison Still Waiting On Word About Stadium Tour

Motley Crue, Def Leppard Stadium Tour Still Up In The Air

More Def Leppard News



advertisement

advertisement


Follow Us: Facebook Twitter Feeds

Contact Us - Privacy - antiMusic Email - Why we are antiMusic - Do Not Sell My Personal Information

Copyright© 1998 - 2020 Iconoclast Entertainment Group All rights reserved.

Please click here for legal restrictions and terms of use applicable to this site. Use of this site signifies your agreement to the terms of use.